Cytosorbents Corporation
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
39.28 |
39.67 |
49.79 |
61.60 |
86.82 |
130.43 |
| Przychód Δ r/r |
0.00% |
0.97% |
25.53% |
23.72% |
40.94% |
50.22% |
| Przychód (min) |
38.95 |
39.31 |
44.06 |
57.97 |
81.70 |
122.73 |
| Przychód (max) |
39.61 |
40.02 |
56.37 |
65.27 |
91.99 |
138.19 |
| EBITDA (średnia) |
-24.66 |
-24.90 |
-31.26 |
-38.67 |
-54.50 |
-81.88 |
| EBIT (średnia) |
-25.72 |
-25.97 |
-32.59 |
-40.32 |
-56.83 |
-85.38 |
| EBIT % |
-65.46% |
-65.46% |
-65.46% |
-65.46% |
-65.46% |
-65.46% |
| Zysk netto (średni) |
-16.11 |
-9.68 |
-7.13 |
0.17 |
13.61 |
33.48 |
| Zysk netto % |
-41.00% |
-24.41% |
-14.32% |
0.28% |
15.67% |
25.67% |
| EPS (średnia) |
-0.28 |
-0.18 |
-0.12 |
-0.01 |
0.25 |
0.61 |
| Liczba analityków (Przychody) |
2 |
2 |
3 |
2 |
1 |
1 |
| Liczba analityków (EPS) |
2 |
1 |
3 |
2 |
1 |
1 |
| symbol |
CTSO |
CTSO |
CTSO |
CTSO |
CTSO |
CTSO |